StonvexLoading…
StonvexStonvexStonvexCore line items from ALTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $100.00M | $1.21B | $822.40M | $516.84M |
Operating Income | $-61.36M | $40.07M | $2.79M | $11.73M |
Net Income | $-41.60M | $46.08M | $9.94M | $13.07M |
EPS (Diluted) | $-0.60 | $0.61 | $0.12 | $0.17 |
Total Assets | $478.32M | $484.95M | $483.40M | $499.20M |
Total Liabilities | $170.23M | $139.74M | $178.21M | $191.19M |
Cash & Equivalents | $36.46M | $50.61M | $36.03M | $50.80M |
Free Cash Flow OCF − CapEx | $-31.70M | $10.44M | $-31.75M | $-172.00K |
Shares Outstanding | 75.15M | 72.78M | 72.80M | 72.81M |